Traverse Biosciences is a privately-held bioscience company established in June 2013 to commercialize a proprietary library of new molecular entities invented at Stony Brook University. Our lead candidate, TRB-N0224, is envisioned as the first FDA-approved, once-daily prescription medication for the prevention and control of canine periodontal disease. We are also pursuing complimentary therapeutic indications for TRB-N0224, as well as additional drug candidates in the pipeline with implications for both human and veterinary medicine. Traverse Biosciences was named to reflect our core mission to successfully navigate the "valley of death" separating early-stage academic technologies from becoming viable commercial products for the benefit of health, society and the economy. Our business model is centered around the achievement of key technical milestones in alignment with a validated market opportunity and a clear exit strategy. With the support of our investors and stakeholders, our goal is to strategically mitigate product development risks and add tangible commercial value to our assets. Please check back soon for additional information!
View Top Employees from Traverse Biosciences Inc.Website | http://www.traversebiosciences.com |
Revenue | $400000 |
Employees | 1 (0 on RocketReach) |
Founded | 2013 |
Address | 25, Stony Brook, New York 11790-3350, US |
Phone | (631) 258-5680 |
Technologies |
JavaScript,
Google Analytics,
G Suite
+10 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Manufacturing, Therapeutics, Health Care |
Competitors | Cassava Sciences, Inc., Central Animal Hospital, Codagenix Inc., South Tyler Animal Clinic, Venetian Pet Hospital |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Traverse Biosciences Inc. employee's phone or email?
The Traverse Biosciences Inc. annual revenue was $400000 in 2024.
Traverse Biosciences Inc. is based in Stony Brook, New York.
The NAICS codes for Traverse Biosciences Inc. are [5417, 54171, 54, 541714, 541].
The SIC codes for Traverse Biosciences Inc. are [87, 873].